Efficacy of the levonorgestrel intrauterine system in treating menorrhagia: Actualities and ambiguities

Amaju Ikomi, Ikomi A, Eric F Pepra, Pepra EF
The journal of family planning and reproductive health care · 2002 · vol. 28(2) , pp. 99–100 · doi:10.1783/147118902101196063 · PMID:12396783 · W1969629374
review OA: bronze CC0 ⤵ 5 in-corpus citations
📄 Open PDF View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-07, 2026-07-18 ⓘ

This review found limited evidence suggesting the levonorgestrel intrauterine system may offer symptomatic relief for menorrhagia in women with fibroids or adenomyosis, though increased expulsion risk exists.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: To review the literature on usage of the levonorgestrel intrauterine system (LNG IUS) in women with fibroids or adenomyosis in an attempt to develop a pragmatic approach when faced with enlarged uteri. DATA SOURCES: Computerised searches of MEDLINE and EMBASE up to December 2000. Some of the information was obtained from references listed in the primary sources and references already known to the authors. STUDY SELECTION: Studies and case reports were excluded if they did not specifically provide information about LNG IUS usage in women with fibroids and adenomyosis. DATA EXTRACTION AND SYNTHESIS: After perusal, each relevant publication was summarised and appraised in terms of whether it contained information relevant to the stated objective. DISCUSSION: This area is sparsely researched, as there were no randomised-controlled studies. One large contraceptive study suggests the LNG IUS has a protective effect from the complications of uterine fibroids and smaller case studies suggest it is also useful in women with symptomatic fibroids. However, there is also evidence of an increased risk of expulsion and there may be a place for initial adjunctive medical treatment to minimise this risk. An observational study and isolated reports of women with adenomyosis report significant symptomatic relief in these women. CONCLUSION: Available data refute the notion that uterine enlargement is a contraindication to insertion of the LNG IUS, but there appear to be reasons for a cautious approach when dealing with pathological uteri.

My notes (saved in your browser only)

Condition tags

endometriosisadenomyosis

MeSH descriptors

Intrauterine Devices, Medicated Levonorgestrel Menorrhagia Progesterone Congeners Endometriosis Endometriosis Female Humans Leiomyoma Leiomyoma Menorrhagia Menorrhagia Uterine Diseases Uterine Diseases Uterine Neoplasms Uterine Neoplasms

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (28)

Cited by (5)

Source provenance

europepmc
last seen: 2026-08-04T06:16:37.499272+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:13:01.552487+00:00
License: CC0 · commercial use OK